Market cap
$11 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
10.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -32.92 | -39.92 | 0.45 | 1.70 |
| EBIT | -- | 49.78 | 34.39 | 14.07 | -298.59 |
| Net Profit | -- | 25.98 | 25.13 | 11.53 | -291.30 |
| EPS | -- | 88.05 | 87.91 | 8.10 | -354.07 |
| Book Value | -- | -- | -98.29 | -62.03 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-25 | Dec-24 | Dec-23 |
| EBIT-Margin
| -2,574.49 | -2,925.97 | -2,513.37 | -2,301.53 | -2,908.58 |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -417.93 | -431.67 | -484.76 | -465.82 | -303.20 |
| Return on Capital
| -221.08 | -223.90 | -258.73 | -216.64 | -187.86 |
| Return on Assets
| -157.77 | -173.25 | -174.63 | -151.15 | -147.52 |
| Debt to Equity (x)
| -- | -- | 4.01 | 0.54 | 2.28 |
Profitability
ROCE
-258.73
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
-258.73
|
-216.64
|
-187.86
|
-201.45
|
-254.81
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-484.76
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
-484.76
|
-465.82
|
-303.20
|
-258.62
|
-645.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-174.63
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
-174.63
|
-151.15
|
-147.52
|
-174.71
|
-218.22
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-2,513.37
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
-2,513.37
|
-2,301.53
|
-2,908.58
|
-4,940.32
|
-1,966.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-3,018.31
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
-3,018.31
|
-2,421.80
|
-2,936.50
|
-4,992.24
|
-2,024.79
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-0.40
--
Year on year growth in net sales
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
-0.40
|
0.00
|
0.69
|
-0.08
|
0.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
34.39
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
34.39
|
21.00
|
0.50
|
-130.62
|
-2,665.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
25.13
--
Year on year growth in profit after tax
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
25.13
|
17.66
|
0.59
|
-126.28
|
-1,891.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
0.88
--
Year on year growth in earnings per share
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
0.88
|
0.55
|
-12.55
|
-1.26
|
-63.69
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
4.01
--
Total debt / Net worth
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
4.01
|
0.54
|
2.28
|
0.23
|
0.41
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
2.46
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
2.46
|
0.40
|
1.61
|
0.09
|
0.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.50
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
0.50
|
1.32
|
0.97
|
4.33
|
7.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
0.44
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
0.44
|
1.26
|
0.91
|
4.29
|
645.64
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-36.15
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
-36.15
|
-19.14
|
-32.17
|
-90.48
|
-33.47
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
20.65
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
20.65
|
23.91
|
39.59
|
48.91
|
3.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.06
--
Sales / Average Total Assets
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
0.06
|
0.06
|
0.05
|
0.03
|
0.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
110.39
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
110.39
|
116.08
|
125.15
|
95.43
|
19.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
141.16
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
141.16
|
564.58
|
373.52
|
-453,227.34
|
-788,695.13
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
401.93
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
401.93
|
2,049.19
|
1,732.19
|
1,137.35
|
469.64
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
-150.39
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
-150.39
|
-1,368.53
|
-1,233.52
|
-454,269.25
|
-789,145.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-0.41
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
-0.41
|
-0.19
|
-0.02
|
-1.94
|
-6.41
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
10.47
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
10.47
|
0.69
|
0.19
|
3.63
|
11.78
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.65
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Mainz Biomed BV (MYNZ)
|
-0.65
|
-0.06
|
-0.04
|
-1.45
|
-6.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|